Top compounds associated with response to VWC2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.1
mRNA tivozanib CTRPv2 pan-cancer AAC -0.055 0.1
mRNA linifanib GDSC1000 pan-cancer AAC -0.052 0.1
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.1
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC -0.05 0.1
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.05 0.1
mRNA WP1130 CTRPv2 pan-cancer AAC 0.052 0.1
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.072 0.1
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.043 0.1
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC -0.096 0.1
Download CSV